Afya (NASDAQ:AFYA) Releases Earnings Results, Beats Estimates By $0.03 EPS

Afya (NASDAQ:AFYA) posted its quarterly earnings results on Friday. The company reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.03, FiscalAI reports. Afya had a return on equity of 17.94% and a net margin of 20.20%.The firm had revenue of $187.80 million for the quarter, compared to the consensus estimate of $189.62 million.

Afya Price Performance

Shares of AFYA traded up $0.43 during trading hours on Friday, reaching $13.84. 174,965 shares of the company traded hands, compared to its average volume of 105,935. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $1.30 billion, a PE ratio of 9.05, a price-to-earnings-growth ratio of 1.45 and a beta of 0.34. Afya has a fifty-two week low of $13.00 and a fifty-two week high of $16.50. The stock has a fifty day simple moving average of $14.27 and a 200 day simple moving average of $14.42.

Wall Street Analyst Weigh In

AFYA has been the topic of a number of recent analyst reports. Bank of America reaffirmed a “neutral” rating on shares of Afya in a research note on Thursday, June 11th. Weiss Ratings cut shares of Afya from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, July 31st. Zacks Research downgraded shares of Afya from a “strong-buy” rating to a “hold” rating in a report on Wednesday, May 6th. JPMorgan Chase & Co. lowered their target price on shares of Afya from $21.50 to $21.00 and set a “neutral” rating on the stock in a research report on Monday, June 22nd. Finally, Wall Street Zen lowered Afya from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 2nd. Six equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $18.00.

Afya News Summary

Here are the key news stories impacting Afya this week:

• Positive Sentiment: Profitability improved: Afya reported second-quarter revenue of $187.8 million, up 10.95% year over year, while net income rose 22.57% to $38.9 million. Diluted EPS increased to $0.43 from $0.40, and operating cash flow reached $64.3 million. Afya Second-Quarter and First-Half 2026 Financial Results
• Positive Sentiment: EPS exceeded the broader consensus: The company’s $0.43 quarterly EPS surpassed the reported consensus estimate of $0.40, while Afya maintained a healthy 20.2% net margin and 17.94% return on equity. Afya Earnings Results
• Positive Sentiment: Cost and balance-sheet trends were supportive: Capital spending declined year over year, cash and equivalents totaled $194.4 million, and total liabilities were broadly unchanged. These factors may reinforce the investment case at a valuation of roughly 9 times earnings.
• Neutral Sentiment: Results were mixed depending on the benchmark: Zacks reported adjusted quarterly EPS of $0.45, slightly below its $0.46 consensus estimate, while revenue also lagged some expectations. Afya Q2 Earnings and Revenues
• Negative Sentiment: Fiscal 2026 revenue guidance was below expectations: Afya projected revenue of $750.2 million to $778.7 million, below the $781.6 million consensus estimate. EPS guidance was not provided in the supplied update, increasing uncertainty around the full-year outlook.
• Negative Sentiment: Insider and institutional selling may weigh on sentiment: Recent data showed 19 insider sales and no insider purchases over six months, while more institutional investors reduced positions than added them. Afya Q2 Earnings and Institutional Activity

Insider Activity

In other news, VP Gomiero Mirella Basolli sold 10,000 shares of Afya stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $14.80, for a total transaction of $148,000.00. Following the completion of the sale, the vice president directly owned 34,530 shares in the company, valued at $511,044. The trade was a 22.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Lelio De Souza Junior sold 41,541 shares of the business’s stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $15.00, for a total transaction of $623,115.00. Following the completion of the transaction, the vice president directly owned 36,204 shares of the company’s stock, valued at approximately $543,060. This represents a 53.43% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 87,745 shares of company stock valued at $1,314,175 in the last three months. 0.80% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in AFYA. Daiwa Securities Group Inc. acquired a new position in shares of Afya during the 4th quarter valued at about $43,000. Militia Capital Partners LP acquired a new position in shares of Afya during the second quarter worth about $71,000. Quantbot Technologies LP acquired a new stake in Afya in the second quarter valued at approximately $117,000. Van ECK Associates Corp boosted its position in Afya by 15.7% in the 3rd quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock valued at $159,000 after buying an additional 1,377 shares during the last quarter. Finally, State of Wyoming purchased a new stake in shares of Afya during the second quarter worth about $164,000. Hedge funds and other institutional investors own 88.02% of the company’s stock.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.